MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
68.57
+1.49 (2.22%)
Aug 14, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $3.3 billion as of August 14, 2026. Its market cap has increased by 659.09% in one year.
Market Cap
3.30B
Enterprise Value
2.89B
1-Year Change
659.09%
Ranking
Category
Stock Price
$68.57
ChartMarket Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $3.30B, an increase of 547.95%. That is a compound annual growth rate of 164.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 3.30B | 133.18% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IDEAYA Biosciences | 3.55B |
| Celldex Therapeutics | 3.40B |
| AbCellera Biologics | 3.33B |
| Arcutis Biotherapeutics | 3.26B |
| uniQure | 3.25B |
| NewAmsterdam Pharma Company | 3.24B |
| Alumis | 3.15B |
| Disc Medicine | 3.08B |